SCHEMBL29600374

SCHEMBL29600374

Cc1cccc(C)c1-c1cc(OCCNCC(C)C)nc(NS(=O)(=O)c2cccc(C(=O)O)c2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
WDR5 P61964 1/20 0.40
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
F2 P00734 1/20 0.38
PRSS1 P07477 1/20 0.38
PRSS2 P07478 1/20 0.38
PRSS3 P35030 1/20 0.38
ALDH1A1 P00352 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
AKR1C3 P42330 4/20 0.38
CYP2C19 P33261 1/20 0.38
MEP1B Q16820 1/20 0.38
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24323163 1.00 WDR5 (0.40) WDR5CASP3SENP8SENP7SENP6
SCHEMBL29457744 0.85 CASP3 (0.42) WDR5CASP3SENP8SENP7SENP6
SCHEMBL26675137 0.85 CASP3 (0.42) WDR5CASP3SENP8SENP7SENP6
SCHEMBL26675140 0.85 CASP3 (0.42) WDR5CASP3SENP8SENP7SENP6
SCHEMBL29457742 0.85 CASP3 (0.42) WDR5CASP3SENP8SENP7SENP6
SCHEMBL24299076 0.84 CASP3 (0.43) WDR5CASP3SENP8SENP7SENP6
SCHEMBL29457912 0.84 CASP3 (0.43) WDR5CASP3SENP8SENP7SENP6
SCHEMBL22502043 0.84 CASP3 (0.40) WDR5CASP3SENP8SENP7SENP6
SCHEMBL22502042 0.84 CASP3 (0.40) WDR5CASP3SENP8SENP7SENP6
SCHEMBL29447220 0.84 CASP3 (0.40) WDR5CASP3SENP8SENP7SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225765-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 EP disclosed
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed